Filing Flows › Harvard Bioscience (HBIO) › Next earnings date
Harvard Bioscience (HBIO) earnings on Nov 10, 2026: what to expect
Harvard Bioscience (HBIO) is expected to report earnings on Nov 10, 2026, in 2 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.17 (−$0.31 to −$0.03, 2 estimates) on revenue of $21.8M, against $0.00 and $20.6M a year ago. It beat the EPS estimate in 33% of the quarters on record; Filing Flows' model gives it a 67% chance of beating next time.
What to watch
Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS $0.00 on revenue of $21.7M, against the analysts' −$0.17.
The last report
Harvard Bioscience reported revenue of $22.7M for the second quarter 2026 (+11% Y/Y), net loss $2.9M: Instruments, Equipment, Software, and Accessories $20.3M, Service, Maintenance, and Warranty Contracts $2.4M. How it makes money → · Every quarter →
Harvard Bioscience's latest quarter
Harvard Bioscience, Q2 2026: revenue $22.7M (+11% year over year), operating margin -4.3%, net loss $2.9M, operating cash flow $325K. The chart follows the revenue to costs, profit and cash.
Questions
When does HBIO report earnings?
Harvard Bioscience is expected to report on Nov 10, 2026.
What are analysts expecting from Harvard Bioscience?
EPS of −$0.17 and revenue of $21.8M for the quarter.
Does Harvard Bioscience usually beat earnings?
It beat the consensus EPS estimate in 33% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.